Maria Clara Gregory’s Post

4 years earlier. An AI algorithm developed by MIT Professional Education is being used by a hospital in Hungary to detect breast cancer 4 years earlier than traditional diagnostic methods. Using a database of 90,000 mammograms, the algorithm was trained to identify minute changes in breast tissue that are impossible to detect with traditional exams. The model was tested with another 60,000 mammograms with known results and was able to identify those that later had a confirmed positive breast cancer diagnosis. This means that with AI, it’s possible to determine patients who will develop breast cancer 4 years earlier than traditional diagnostic models would allow. The impact of artificial intelligence on health will be immense. This technology will affect all business areas and how we live, but the impact on health will be enormous. The benefits will be tremendous.

E se junto disso colocar uma impressao 3d de orgãos para imprimir o corpo do individuo em uma versao saudavel ? What if, along with this, a 3D print of organs was added to print the individual's body in a healthy version? #future #IA #health #FontainOfYouth

Two weeks ago, while presenting our experiences from the perspective of a scientific and health association in Brazil and representing BSSO and my country during the International Forum of Association Leaders in Barcelona (Spain), I highlighted the importance of dialogue with governments and legislators in all instances. I explained to the audience that political changes should not prevent us from continuing to develop our missions and objectives: "We must look to the future, without forgetting our core values". For a medical association, there is no right/left division—what matters is the construction of dialogue, proposing solutions, and supporting public policy actions. In our case, this was the path to impacting the lives of over 200 million people. Back in Brazil, last week we received with great joy the announcement by the Minister of Health regarding the incorporation of a new public policy (video laparoscopy for cancer patients) into the Unified Health System (SUS) — our public healthcare system in Brazil. This is a demand we (as a health association) have been following closely, and I have been learning from the efforts made by our different boards of directors since I joined BSSO almost five years ago. Today, this effort culminated in turning it into an official public policy in Brazil.   This is a collective effort, driven by the resilience of many of our directors and presidents from different administrations, through dialogues in meetings in our federal capital and at various forums and opportunities. It also involves preparing and publishing opinion articles in major newspapers and on social media posts, where we explain the importance of this to our citizens. Knowing that all our small efforts, along with our resilience in the face of challenges, help us positively impact the lives of so many people—our population, our families, and our friends—is what drives us every day to take action. We all win!

Imagine um futuro em que a juventude não é limitada pelo tempo. Eucerin marca o início de uma nova geração anti-idade. Após 15 anos de pesquisa e 50.000 ativos testados, a marca desenvolveu o Age Clock, tecnologia patenteada capaz de medir a idade biológica da pele. A partir dessa descoberta nasce o Novo Eucerin Sérum Epigenetic, com Epicelline, ingrediente ativo potente e exclusivo, que restaura o padrão epigenético da juventude e reduz a idade biológica das células. Essa inovação revolucionária é capaz de reverte os 10 sinais do envelhecimento, isso inclui firmeza, efeito lifting, redução de rugas, redução de linhas finas, contornos, hidratação, brilho, rejuvenescimento, uniformidade e suavidade da pele. Proporcionando uma pele até 5 anos mais jovem em 4 semanas. Eucerin mais uma vez, fazendo história com o poder transformador do cuidado dermatológico.

In every language…. Any time

These cells have nucleoli and deep staining cytoplasm of a blast... My impression is Acute Monoblastic Leukaemia. Flow Cytometry required to properly classify the leukaemia.

Breast Cancer Prevention: Take Charge of Your Health October is Breast Cancer Awareness Month, a vital reminder to prioritize our health and well-being. Here are some important steps to help reduce your risk: Regular Screenings: Schedule annual mammograms starting at age 40, or earlier if you have a family history of breast cancer. Early detection can save lives. Know Your Body: Perform regular self-exams to familiarize yourself with how your breasts normally look and feel. Report any changes to your doctor promptly. Healthy Lifestyle: Maintain a balanced diet, exercise regularly, and limit alcohol consumption. These lifestyle choices can significantly impact your risk. Stay Informed: Educate yourself about risk factors, including genetics, age, and personal health history. Awareness is key to prevention. Support Each Other: Encourage friends and family to take preventive measures and share information. Together, we can create a supportive community focused on health.

🌍✨ CIBIT's researcher, Nuno Madeira, joins the European VOLABIOS project to revolutionize the early diagnosis and treatment of schizophrenia! 💡 With €8 million in funding from the European Horizon program, this initiative brings together 18 partners from 11 countries to develop more advanced and cost-effective tools for schizophrenia diagnosis, aiming to improve patient's quality of life and optimize monitoring strategies with the support of artificial intelligence and molecular biomarkers. 🧠❤️ 🔬 At UC, research will be led by the teams of Bruno Manadas (Center for Neuroscience and Cell Biology and CIBB), Nuno Madeira (FMUC - Faculdade de Medicina da UC, CIBIT, ULS de Coimbra), and Joel Arrais (Department of Informatics Engineering, CISUC - Centre for Informatics and Systems of the University of Coimbra), focusing on patient recruitment and large-scale proteomic profile analysis in the context of First Psychotic Episode.

🌟 Revolutionizing Alzheimer's Diagnosis with AI! 🌟 🚀 Excited to share a glimpse into the future of Alzheimer's diagnosis! At just 27, I had the privilege of discussing my groundbreaking research on Portugal's most-watched TV channel this past Saturday (SIC, SIC Notícias). I am blending data from smartwatches and mobile technologies, and artificial intelligence at the University of Geneva to pioneer early diagnostic solutions for Alzheimer's disease. 🧠 With over 90% of Alzheimer's cases diagnosed in individuals over 65, my work aims to passively and ubiquitously detect precursors of the disease in people as young as 40 - long before clinical symptoms emerge. By harnessing AI, I am sifting through a vast dataset to predict Alzheimer's onset earlier than ever before. 💡 The first fruits of my labor are on the horizon, with preliminary results expected in the next 3-4 months. This research could be a game-changer in preemptively tackling one of the most challenging diseases affecting our aging population. 📢 We're currently seeking volunteers in Switzerland to participate in our first research study. This is a unique opportunity to contribute to groundbreaking work that could change the future of Alzheimer's diagnosis and care. If you want to join us on this journey, please sign up at https://lnkd.in/duyGTZUa. Your participation could make a monumental difference! 🤖 AI isn't just a tool; it's a revolution in the making, poised to transform healthcare from the ground up. I'm thrilled to be at the forefront of this exciting journey, where every data point brings us closer to turning the tide against Alzheimer's disease. Let's embrace the power of AI for a healthier tomorrow. #Alzheimer #ArtificialIntelligence #AIForGood #Research #Technology #CognitiveDecline #Cognition #PersonalizedMedicine #AlzheimersResearch #InnovationInHealthcare #EarlyDiagnosis #SmartTechnology #FutureOfMedicine 📺 Note: The interview is available in Portuguese and provides an in-depth look at my research and aspirations. Dive into the details of this innovative approach to healthcare! Katarzyna Wac Centre Universitaire d’Informatique (CUI) - UNIGE Geneva School of Economics and Management - UNIGE Alzheimer's Disease International

I’m thrilled to share the latest innovation from Siemens Healthineers: a portable CT machine - somatom on site; that allows radiographers to perform CT scans directly at the patient's bedside. This cutting-edge technology brings numerous benefits to patient care: - **Enhanced Patient Safety**: Eliminates the need to transport critically ill or immobile patients to the radiology department, reducing associated risks. - **Improved Comfort**: Patients can remain in their own beds, ensuring a more comfortable experience. - **Streamlined Workflow**: Speeds up the diagnostic process, allowing for quicker clinical decisions and treatment initiation. - **High-Quality Imaging**: Despite its portability, this machine delivers high-resolution images comparable to those from traditional CT scanners. The portable CT machine is a game-changer, particularly for emergency and intensive care settings. By bringing the CT scanner to the patient, we can provide faster, safer, and more efficient care. Kudos to Siemens Healthineers for this remarkable advancement in medical technology!